Epidemiology and Risk Factors for Upper Gastrointestinal Bleeding

Thomas Tielleman, Daniel Bujanda, Byron Cryer

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Although the incidence of nonvariceal upper gastrointestinal bleeding (UGIB) has been decreasing worldwide, nonvariceal UGIB continues to be a significant problem. Even with the advent of advanced endoscopic procedures and potent medications to suppress acid production, UGIB carries significant morbidity and mortality. Some of the most common risk factors for nonvariceal UGIB include Helicobacter pylori infection, nonsteroidal antiinflammatory drugs (NSAIDs), aspirin, selective serotonin reuptake inhibitors, and other antiplatelet and anticoagulant medications. In patients with cardiovascular disease and kidney disease, UGIB tends to be more severe and has greater morbidity. Many of the newer NSAIDs have been removed from the market.

Original languageEnglish (US)
Pages (from-to)415-428
Number of pages14
JournalGastrointestinal Endoscopy Clinics of North America
Volume25
Issue number3
DOIs
StatePublished - Jul 1 2015

Fingerprint

Epidemiology
Hemorrhage
Anti-Inflammatory Agents
Morbidity
Serotonin Uptake Inhibitors
Kidney Diseases
Helicobacter Infections
Helicobacter pylori
Pharmaceutical Preparations
Anticoagulants
Aspirin
Cardiovascular Diseases
Acids
Mortality
Incidence

Keywords

  • Aspirin
  • Clopidogrel
  • Epidemiology
  • Helicobacter pylori
  • Incidence
  • Mortality
  • NSAIDs
  • Risk factors

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Epidemiology and Risk Factors for Upper Gastrointestinal Bleeding. / Tielleman, Thomas; Bujanda, Daniel; Cryer, Byron.

In: Gastrointestinal Endoscopy Clinics of North America, Vol. 25, No. 3, 01.07.2015, p. 415-428.

Research output: Contribution to journalArticle

@article{fa93d71b6c42444e98a691e127faea64,
title = "Epidemiology and Risk Factors for Upper Gastrointestinal Bleeding",
abstract = "Although the incidence of nonvariceal upper gastrointestinal bleeding (UGIB) has been decreasing worldwide, nonvariceal UGIB continues to be a significant problem. Even with the advent of advanced endoscopic procedures and potent medications to suppress acid production, UGIB carries significant morbidity and mortality. Some of the most common risk factors for nonvariceal UGIB include Helicobacter pylori infection, nonsteroidal antiinflammatory drugs (NSAIDs), aspirin, selective serotonin reuptake inhibitors, and other antiplatelet and anticoagulant medications. In patients with cardiovascular disease and kidney disease, UGIB tends to be more severe and has greater morbidity. Many of the newer NSAIDs have been removed from the market.",
keywords = "Aspirin, Clopidogrel, Epidemiology, Helicobacter pylori, Incidence, Mortality, NSAIDs, Risk factors",
author = "Thomas Tielleman and Daniel Bujanda and Byron Cryer",
year = "2015",
month = "7",
day = "1",
doi = "10.1016/j.giec.2015.02.010",
language = "English (US)",
volume = "25",
pages = "415--428",
journal = "Gastrointestinal Endoscopy Clinics of North America",
issn = "1052-5157",
publisher = "W.B. Saunders Ltd",
number = "3",

}

TY - JOUR

T1 - Epidemiology and Risk Factors for Upper Gastrointestinal Bleeding

AU - Tielleman, Thomas

AU - Bujanda, Daniel

AU - Cryer, Byron

PY - 2015/7/1

Y1 - 2015/7/1

N2 - Although the incidence of nonvariceal upper gastrointestinal bleeding (UGIB) has been decreasing worldwide, nonvariceal UGIB continues to be a significant problem. Even with the advent of advanced endoscopic procedures and potent medications to suppress acid production, UGIB carries significant morbidity and mortality. Some of the most common risk factors for nonvariceal UGIB include Helicobacter pylori infection, nonsteroidal antiinflammatory drugs (NSAIDs), aspirin, selective serotonin reuptake inhibitors, and other antiplatelet and anticoagulant medications. In patients with cardiovascular disease and kidney disease, UGIB tends to be more severe and has greater morbidity. Many of the newer NSAIDs have been removed from the market.

AB - Although the incidence of nonvariceal upper gastrointestinal bleeding (UGIB) has been decreasing worldwide, nonvariceal UGIB continues to be a significant problem. Even with the advent of advanced endoscopic procedures and potent medications to suppress acid production, UGIB carries significant morbidity and mortality. Some of the most common risk factors for nonvariceal UGIB include Helicobacter pylori infection, nonsteroidal antiinflammatory drugs (NSAIDs), aspirin, selective serotonin reuptake inhibitors, and other antiplatelet and anticoagulant medications. In patients with cardiovascular disease and kidney disease, UGIB tends to be more severe and has greater morbidity. Many of the newer NSAIDs have been removed from the market.

KW - Aspirin

KW - Clopidogrel

KW - Epidemiology

KW - Helicobacter pylori

KW - Incidence

KW - Mortality

KW - NSAIDs

KW - Risk factors

UR - http://www.scopus.com/inward/record.url?scp=84937572718&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84937572718&partnerID=8YFLogxK

U2 - 10.1016/j.giec.2015.02.010

DO - 10.1016/j.giec.2015.02.010

M3 - Article

C2 - 26142028

AN - SCOPUS:84937572718

VL - 25

SP - 415

EP - 428

JO - Gastrointestinal Endoscopy Clinics of North America

JF - Gastrointestinal Endoscopy Clinics of North America

SN - 1052-5157

IS - 3

ER -